Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • rainbow over text: 'thank you NHS'
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Mediclinic International plc (MDC) Ordinary 10p

Sell:299.80p Buy:300.80p 0 Change: 3.20p (1.08%)
FTSE 250:2.26%
Market closed Prices as at close on 5 June 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 3.20p (1.08%)
Market closed Prices as at close on 5 June 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 3.20p (1.08%)
Market closed Prices as at close on 5 June 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Mediclinic International plc (Mediclinic) is an international private healthcare services provider. Mediclinic is focused on providing acute-care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic’s operational divisions includes Hirslanden Switzerland, Mediclinic Southern Africa and Mediclinic Middle East. Mediclinic comprises of 77 hospitals, five sub-acute hospitals, 14 day case clinics and 22 outpatient clinics. Hirslanden Switzerland operates 17 hospitals, two day case clinics and three outpatient clinics in Switzerland with over 1900 inpatient beds. Mediclinic Southern Africa operates 53 hospitals, five sub-acute hospitals and 10 day case clinics across South Africa and three hospitals in Namibia with over 8500 inpatient beds. Mediclinic Middle East operates seven hospitals, two day case clinics and 19 outpatient clinics with over 900 inpatient beds in the United Arab Emirates.

Contact details

6th Fl, 65 Gresham Street
United Kingdom
+44 (020) 79549600

Important dates

Future events
AGM 22 July 2020 22/07/20
Past events
Final results 02 June 2020 02/06/20
Final results 21 May 2020 21/05/20
Trading Announcement 17 April 2020 17/04/20
Trading Announcement 14 April 2020 14/04/20
Interim dividend payment date 17 December 2019 17/12/19
Trading Announcement 12 December 2019 12/12/19
Interim ex-dividend date 05 December 2019 05/12/19
Interim results 14 November 2019 14/11/19
Trading Announcement 16 October 2019 16/10/19
Final dividend payment date 29 July 2019 29/07/19
AGM 24 July 2019 24/07/19
Annual report 21 June 2019 21/06/19
Final ex-dividend date 13 June 2019 13/06/19

General stock information

Market cap:
£2.21 billion
Shares in issue:
737.21 million
Health Care Equipment & Services
London Stock Exchange
Sterling pence
FTSE 250,FTSE 350,FTSE All Share

Key personnel

  • Ronnie van der Merwe
    Chief Executive Officer, Executive Director
  • Jurgens Myburgh
    Chief Financial Officer, Executive Director
  • David Hadley
    Chief Executive Officer - Mediclinic Middle East
  • Daniel Liedtke
    Chief Executive Officer - Hirslanden
  • Koert Pretorius
    Chief Executive Officer - Mediclinic Southern Africa
  • Magnus Oetiker
    Chief Human Resources and Corporate Development Officer
  • Dirk Le Roux
    Chief Information Officer
  • Gert Hattingh
    Chief Corporate Services Officer
  • Rene Toua
    Chief Clinical Officer
  • Dame Beale
    Non-Executive Independent Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.